Congress demands transparency on animal research funded by your taxes

What it does

This bill requires the National Institutes of Health to collect and publicly disclose detailed annual data on animal use in federally funded research—including species, numbers, and whether pain-relief drugs were used. Research institutions must file forms breaking down animals by pain category and breeding status, and NIH must post this data in a searchable public database within 3 months of filing. The requirement takes effect 2 years after enactment.

Why we flagged it

The bill's core mechanism is a data-collection and public-disclosure mandate. It does not restrict, ban, or regulate animal research itself—only requires NIH-funded entities to report standardized information about their practices and make it publicly searchable.

What the text implies

• Public database may enable animal-rights advocates to target specific institutions or researchers, potentially chilling some research or creating reputational pressure independent of regulatory action.
• Detailed pain-category breakdowns could reveal research methodologies and animal-use patterns that competitors or foreign actors might exploit for competitive or espionage purposes.
• 2-year implementation delay allows institutions time to prepare but also creates a window during which current practices remain opaque to the public.
• Bill does not mandate changes to research practices themselves—only disclosure—so institutions conducting high-pain research remain compliant if they report accurately.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill increases transparency and public accountability over federally funded animal research by mandating disclosure of previously opaque data. Citizens gain the ability to see how their tax dollars fund animal use and can scrutinize research practices, while the compliance burden on institutions is modest (annual reporting) and does not restrict research itself.

Named in the bill

National Institutes of Health (NIH), Public Health Service Act, Animal care committees, Biomedical and behavioral research entities, Bristol Myers Squibb (BMY), Gilead Sciences (GH), Pfizer (PFE), DaVita (DVA), Johnson & Johnson (JNJ)

Where it stands

25 cosponsors: 17 Democrats, 8 Republicans.

• May 8, 2025 — Introduced · Congress.gov: “Introduced in House”
• May 8, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $42,169 in lobbying spend. A filing names 9 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Nicole Malliotakis, the sponsor, reported $1,140,250 in PAC receipts in the 2026 cycle.

• Physicians Committee for Responsible Medicine — $42,169 on 1 filing

Lobbying Disclosure Act filings through Jul 16, 2026. A filing shows who paid to lobby on a bill it names, not what changed.